Advanced search
Publication Cover
Journal of Asthma Volume 48, 2011 - Issue 5
Submit an article Journal homepage
429
Views
11
CrossRef citations to date
0
Altmetric
Biomarkers

Changes in Total IgE Plasma Concentration Measured at the Third Month during Anti-IgE Treatment Predict Future Exacerbation Rates in Difficult-to-Treat Atopic Asthma: A Pilot Study

Roberto W. Dal NegroLung Department, Orlandi General Hospital, Bussolengo, Verona, Italy.;Centro Nazionale Studi Farmacoeconomia e Farmacoepidemiologia Respiratoria—CESFAR, Verona, Italy.
, M.D.,
Massimo GuerrieroDipartimento di Economie Società ed Istituzioni (ESI), Statistical Section, University of Verona, Verona, Italy.
, Ph.D.,
Claudio MichelettoLung Department, Orlandi General Hospital, Bussolengo, Verona, Italy.Correspondence[email protected]
, M.D.,
Silvia TognellaLung Department, Orlandi General Hospital, Bussolengo, Verona, Italy.
, M.D. &
Marilia ViscontiLung Department, Orlandi General Hospital, Bussolengo, Verona, Italy.
, B.Sc.
Pages 437-441 | Published online: 23 May 2011

Citations (11)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Stephanie Chen, Sarowar Golam, Julie Myers, Chris Bly, Harry Smolen & Xiao Xu. (2018) Systematic literature review of the clinical, humanistic, and economic burden associated with asthma uncontrolled by GINA Steps 4 or 5 treatment. Current Medical Research and Opinion 34:12, pages 2075-2088.
Read now
Yukiko Iino, Mariko Hara, Masayo Hasegawa, Shingo Matsuzawa, Akihiro Shinnabe, Hiromi Kanazawa & Naohiro Yoshida. (2014) Effect of omalizumab on biomarkers in middle ear effusion in patients with eosinophilic otitis media. Acta Oto-Laryngologica 134:4, pages 366-372.
Read now
Robert G. Hamilton. (2012) Inaccuracies in Total Serum IgE Measurements by Immulite Caused by Omalizumab in Specimens. Journal of Asthma 49:3, pages 324-325.
Read now

Articles from other publishers (8)

Serafeim Chrysovalantis Kotoulas, Ioanna Tsiouprou, Eva Fouka, Athanasia Pataka, Despoina Papakosta & Konstantinos Porpodis. (2022) Omalizumab: An Optimal Choice for Patients with Severe Allergic Asthma. Journal of Personalized Medicine 12:2, pages 165.
Crossref
Jean Bousquet, Marc Humbert, Peter G. Gibson, Konstantinos Kostikas, Xavier Jaumont, Pascal Pfister & Francis Nissen. (2021) Real-World Effectiveness of Omalizumab in Severe Allergic Asthma: A Meta-Analysis of Observational Studies. The Journal of Allergy and Clinical Immunology: In Practice 9:7, pages 2702-2714.
Crossref
Jing Li, Changzheng Wang, Chuntao Liu, Jian Kang, Lingfei Kong, Yijiang Huang, Shuang Liu, Mao Huang, Lu Wang, Robert Fogel, Xavier Jaumont, Jing Yang & Nanshan Zhong. (2020) Efficacy predictors of omalizumab in Chinese patients with moderate-to-severe allergic asthma: Findings from a post-hoc analysis of a randomised phase III study. World Allergy Organization Journal 13:12, pages 100469.
Crossref
Cong-Lin Liu, Yi Wang, Mengyang Liao, Marcela M. Santos, Cleverson Fernandes, Galina K. Sukhova, Jin-Ying Zhang, Xiang Cheng, Chongzhe Yang, Xiaozhu Huang, Bruce Levy, Peter Libby, Gongxiong Wu & Guo-Ping Shi. (2016) Allergic lung inflammation promotes atherosclerosis in apolipoprotein E-deficient mice. Translational Research 171, pages 1-16.
Crossref
Philip J. Lowe, Panayiotis Georgiou & Janice Canvin. (2015) Revision of omalizumab dosing table for dosing every 4 instead of 2 weeks for specific ranges of bodyweight and baseline IgE. Regulatory Toxicology and Pharmacology 71:1, pages 68-77.
Crossref
Hiroko Mizuma, Akihiko Tanaka, Yoshitaka Uchida, Akiko Fujiwara, Ryo Manabe, Hitomi Furukawa, Naota Kuwahara, Yosuke Fukuda, Tomoyuki Kimura, Megumi Jinno, Shin Ohta, Mayumi Yamamoto, Satoshi Matsukara, Mitsuru Adachi & Hironori Sagara. (2015) Influence of Omalizumab on Allergen-Specific IgE in Patients with Adult Asthma. International Archives of Allergy and Immunology 168:3, pages 165-172.
Crossref
Yukiko Iino, Mariko Hara, Masayo Hasegawa, Shingo Matsuzawa, Akihiro Shinnabe, Hiromi Kanazawa & Naohiro Yoshida. (2012) Clinical Efficacy of Anti-IgE Therapy for Eosinophilic Otitis Media. Otology & Neurotology 33:7, pages 1218-1224.
Crossref
C. Taill?. (2011) Traitement de l?asthme. Revue des Maladies Respiratoires Actualit?s 3:5, pages 500-503.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.